2537. Population Pharmacokinetics of Isavuconazole in Pediatric Patients

BACKGROUND: Isavuconazole (ISAV) is approved for the treatment of invasive aspergillosis (IA) and invasive mucormycosis (IM) in adults; however, there are limited data for its use in pediatric participants. The aim of this analysis is to develop an integrated population pharmacokinetic (PPK) model f...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Amit, Parasrampuria, Dolly A, Kovanda, Laura, Sinnar, Shamim, Tannenbaum, Stacey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678532/
http://dx.doi.org/10.1093/ofid/ofad500.2154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678532/
http://dx.doi.org/10.1093/ofid/ofad500.2154

Ejemplares similares